Bravelle 75I.U Injection belongs to the class of drugs called hormones used in the treatment of female infertility in women whose ovaries do not produce eggs and in women receiving treatments like IVF (in-vitro fertilization). Infertility is unable to become pregnant after trying for a year. Female infertility may be caused due to different factors affecting ovulation (release of an egg from the ovary), fertilization (fusion of sperm and egg) and implantation (fertilized egg attaches to uterus lining).

Bravelle 75I.U Injection contains Urofollitropin which works similarly to follicle-stimulating hormone (natural sex hormone). Bravelle 75I.U Injection increases oestrogen production that stimulates the development of the egg and mature follicle in women having ovulation (release of an egg from the ovary) problems and those undergoing IVF treatments.

Take Bravelle 75I.U Injection as prescribed by your doctor. You are advised to take Bravelle 75I.U Injection for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience headache, stomach pain, nausea, vomiting, pelvic pain, hot flushes (sudden feeling of warmth) or inflammation of the throat and nasal passage. Most of these side effects of Bravelle 75I.U Injection do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Bravelle 75I.U Injection or any other medicines, please tell your doctor. Avoid taking Bravelle 75I.U Injection if you are pregnant or breastfeeding and consult a doctor before taking Bravelle 75I.U Injection. Avoid taking Bravelle 75I.U Injection if you have tumours of the pituitary gland, hypothalamus, uterus, breasts or ovaries, vaginal bleeding, uterus fibroids, early menopause, malformations of sexual organs, cysts on ovaries or enlarged ovaries. If you experience weight gain, stomach pain, diarrhoea, nausea, vomiting, difficulty in breathing, decreased urination or swelling in the stomach after a few days of taking Bravelle 75I.U Injection last dose, please consult a doctor immediately as these might be signs of high levels of activity in the ovaries.

Bravelle 75I.U Injection contains Urofollitropin which works similarly to follicle-stimulating hormone (natural sex hormone). Bravelle 75I.U Injection increases estrogen production that stimulates the development of the egg and mature follicle in women having ovulation (release of an egg from the ovary) problems and those undergoing IVF treatments.

If you are allergic to Bravelle 75I.U Injection or any other medicines, please tell your doctor. If you have hyperprolactinemia (high levels of prolactin hormone), tumours of the pituitary gland, hypothalamus, uterus, breasts or ovaries, underactive adrenal or thyroid glands, blood clots, vaginal bleeding, uterus fibroids, early menopause, malformations of sexual organs, cysts on ovaries or enlarged ovaries, inform your doctor before taking Bravelle 75I.U Injection. Avoid taking Bravelle 75I.U Injection if you are pregnant or breastfeeding and consult a doctor before taking Bravelle 75I.U Injection. If you experience weight gain, stomach pain, diarrhoea, nausea, vomiting, difficulty in breathing, decreased urination or swelling in the stomach after few days of taking Bravelle 75I.U Injection last dose, please consult a doctor immediately as these might be signs of high levels of activity in the ovaries.